Finance

Beta
Lists
CHM:ASX
Chimeric Therapeutics Ltd
A$0.10
-4.76%
(-0.0050) 1D
May 28, 4:10:17 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CHM...
Open
A$0.10
High
A$0.10
Low
A$0.10
Mkt. cap
5.08M
Avg. vol.
126.78K
Volume
105.87K
52-wk high
A$0.60
52-wk low
A$0.10
EPS
-A$0.77
Shares outstanding
53.18M
Open
A$0.10
High
A$0.10
Low
A$0.10
Mkt. cap
5.08M
Avg. vol.
126.78K
Volume
105.87K
52-wk high
A$0.60
52-wk low
A$0.10
EPS
-A$0.77
Shares outstanding
53.18M
News stories
From sources across the web
About Chimeric Therapeutics Ltd
CEO-
Employees-
Founded2020
Headquarters-
SectorBiotechnology
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.57M
3.57M
1.31M
1.31M
Cost of goods sold
423.38K
423.38K
-
-
Cost of revenue
423.38K
423.38K
-
-
Research and development expenses
3.32M
3.32M
399.44K
399.44K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.55M
1.55M
1.35M
1.35M
Operating expense
5.06M
5.06M
1.94M
1.94M
Total operating expenses
5.48M
5.48M
1.94M
1.94M
Operating income
-1.91M
-1.91M
-634.86K
-634.86K
Other non operating income
-
-
-
-
EBT including unusual items
-3.80M
-3.80M
-5.59M
-5.59M
EBT excluding unusual items
-2.02M
-2.02M
-709.86K
-709.86K
Income tax expense
-13.52K
-13.52K
21.60K
21.60K
Effective tax rate
0.36%
0.36%
-0.39%
-0.39%
Other operating expenses
-
-
-
-
Net income
-3.79M
-3.79M
-5.61M
-5.61M
Net profit margin
-106.20%
-106.20%
-428.19%
-428.19%
Earnings per share
-
-
-
-
Interest and investment income
11.03K
11.03K
13.78K
13.78K
Interest expense
-62.83K
-62.83K
-88.79K
-88.79K
Net interest expenses
-51.80K
-51.80K
-75.01K
-75.01K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.64M
-1.64M
-391.47K
-391.47K
Gain or loss from assets sale
146.00
146.00
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more